An increased albumin excretion rate (AER) is associated with impaired glucose tolerance and diabetes mellitus in some populations, but data on Americans of Northern European origin are lacking. In 1986-1987, AER and creatinine clearance were measured in 455 adults in a survey of the population of Wadena, Minnesota. Thirty-five subjects (8%) had an AER > 15 /xg/minute, and eight of these had overt proteinuria (AER > 175 ^g/minute). AER and creatinine clearance were uncorrelated except when AER was increased. Unadjusted mean AER in a stratified random sample of adults (n = 374) was 3.6 /ig/minute. Adjusted values for 277 subjects with normal glucose tolerance and for 80 subjects with impaired glucose tolerance were very similar (3.8 and 3.7 (xg/minute, respectively), whereas mean AER was 5.4 /ig/minute for persons with non-insulin-dependent diabetes mellitus (NIDDM) who were not taking insulin and 9.4 jig/minute for persons with NIDDM who were taking insulin (p < 0.0001). After adjustment for age, mean creatinine clearance was unrelated to glucose tolerance. Systolic blood pressure was a major determinant of increased AER (p < 0.0001) and lowered creatinine clearance (p = 0.0011), independently of diabetes. AER was stable over 5 years among the 321 cases who were not taking insulin and were not severely hypertensive. The decrease in creatinine clearance was greater in ex-smokers and current smokers than in nonsmokers. The authors conclude that hypertension and NIDDM were independently associated with the risk of kidney damage in this population, as indicated by a higher AER. High-normal blood pressure, but not impaired glucose tolerance, was associated with microalbuminuria. These relatively mild changes may reflect an ethnically based resistance to the damaging effects of hyperglycemia on the kidney. Smoking may accelerate the aging-related decline in glomerular filtration rate. Am J Epidemiol 1997; 145:91-102. albuminuria; Caucasoid race; creatinine clearance; diabetes mellitus, insulin-dependent; diabetes mellitus, non-insulin-dependent; glucose intolerance; glycosuria; kidney With the advent of highly sensitive methods for measurement of albumin in urine (1), it has become possible to demonstrate that persons with insulindependent diabetes mellitus (IDDM) (1-4) or high blood pressure (1, 5-13) may show increased rates of urinary albumin excretion before they have developed overt kidney damage, defined as a qualitatively tested albumin level greater than 30 mg/dl. This intermediate Abbreviations: AER, albumin excretion rate; IDDM, insulindependent diabetes mellitus; NIDDM, non-insulin-dependent diabetes mellitus.
range of urinary albumin excretion rate (AER), designated "microalbuminuria," is a predictor not only of impending nephropathy but also of increased mortality from cardiovascular disease. There is supporting literature based on studies carried out in the region where IDDM is especially prevalent: Northern Europe (14) (15) (16) .
Until recently, there has been less information available on the occurrence of increased AER in persons with the common, non-insulin-dependent form of diabetes mellitus (NIDDM). Although this gap is being filled (17) (18) (19) (20) (21) , there remains a relative lack of information on factors potentially related to renal disease in persons with NIDDM as well as in nondiabetics, such as age, sex, impaired glucose tolerance, change in kidney function over time, ethnic background, and the relation between albuminuria and creatinine clearance. Cross-sectional or prospective studies based on North American Caucasian populations have been few (22) .
Because of this lack of information-especially from community-based studies-we measured AER, creatinine clearance, and other health-related variables in the adult residents of Wadena, Minnesota, a small town with an ethnically well-defined population of Northern European background who were available for prospective study over a 5-year period (1986-1987 to 1991-1992) . We were especially interested in relations between impaired glucose tolerance, highnormal blood pressure, and increased albumin excretion, and in how results found in the Wadena population would compare with those of studies carried out in other ethnic groups both similar and dissimilar.
MATERIALS AND METHODS

Subjects
The community of Wadena, Minnesota (population 4,699, according to the 1980 US Census) was selected for a prospective, population-based study concerning the nature and effects of impaired glucose tolerance, NIDDM, and IDDM. Wadena is a stable community 200 km from the metropolitan area of Minneapolis-St. Paul; over 85 percent of participants reported having parents or grandparents from Germany, Scandinavia, or die British Isles, the remainder from other parts of Europe. The present residents consist mostly of second and third generation descendants of 19th century immigrants.
Two cohorts of Wadena residents aged >20 years were recruited: a stratified random sample and a separate cohort representing all persons known to have physician-defined diabetes mellitus. The stratified random sample was based on a list drawn from a 99 percent complete city-wide census including over 1,900 households; subjects were stratified according to age (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) (46) (47) (48) (49) (50) (51) (52) (53) (54) (55) (56) (57) (58) (59) , and >60 years), sex, and selfreported use of prescription medication. The second cohort consisted of all adults known to Wadena caregivers to have diabetes; this information was updated from an earlier study (23) .
A total of 476 individuals participated in the baseline studies in 1986-1987. Baseline participation rates were 65 percent (389/600) of the potential stratified random sample and 71 percent (87/123) of the previously defined diabetic subjects.
Out of 476 enrolled participants, 455 had complete data from baseline blood and urine collections, including both AER and creatinine clearance. Five-year follow-up testing was carried out in 1991-1992; 343 participants followed the entire study protocol (75 percent of the original group of 455). Of the 112 who did not return for the 5-year examination, 31 percent had died; other reasons for dropping out included major illness and moving out of the state of Minnesota. Further details on the study protocol have been furnished in previous publications (24, 25) .
The study protocol was reviewed and approved by the Committee on the Use of Human Subjects in Research of the University of Minnesota. Written informed consent was secured from all participants.
Procedures
Study subjects participated in two mornings of testing and data collection, with the second session occurring within 10 days of the first session.
The central feature of one test morning was a standard oral glucose tolerance test, carried out according to the procedure recommended by the National Diabetes Data Group (26) and the World Health Organization (27) . A few subjects previously known to be diabetic were classified as having IDDM on the basis of medical record review, including a physician statement of continuous insulin treatment and a history of ketosis. All other diabetic subjects were considered to have NIDDM, and were further subclassified according to whether or not they were taking insulin.
The central feature of the odier test morning was a liquid-meal challenge test consisting of 480 ml of the food supplement Ensure-Plus (Ross Laboratories, Columbus, Ohio), containing 95 g of carbohydrate, 26 g of protein, and 25 g of fat and providing a total of 710 kcal of energy.
tolerance and Ensure-Plus tests, beginning at 8:00 a.m. Women's tests were scheduled to avoid menstrual periods. While urine was being collected, each subject was asked to drink an additional 250 ml of water to promote urine flow. In 96.3 percent of the tests, urine collections were completed within 10 minutes of the target time of 260 minutes. Venous blood samples were taken for measurement of serum creatinine, plasma glucose, glycosylated hemoglobin, and other substances.
Laboratory methods
Urine was stored at -20°C for an average period of 2.5 years for baseline specimens and an average of 6 months for 5-year follow-up studies. Under these conditions, urinary albumin concentration did not change over a period of 3 years, with a correlation coefficient (r) of 0.96 between initial and repeat values (B. Chavers, unpublished observations), which agrees with the findings of others (28) . Albumin concentration was measured with a solid-phase fluorescent immunoassay (29) . The albumin concentrations of duplicate samples were calculated from a standard curve. The coefficients of variation at 7 pig/ml, expressed as daily within-run and between-run values, were 6.0 percent and 6.7 percent, respectively. The normal AER for our laboratory, based on measurements made in 100 normal adults, is 8.3 mg per 24 hours (standard deviation, 4.8; range, 1.1-21.0), or 5.8 /xg/minute (standard deviation, 3.3) with a range of 0. 42-14.6 (30) . A urinary AER of at least 15 jig/minute but less than 175 /xg/minute was considered microalbuminuria. Excretion of si75 /xg/minute was always associated with a positive dipstick test for albumin, indicating overt proteinuria. These cutpoints may be compared with the levels of 20 and 200 ^tg/minute proposed as the international definition of microalbuminuria measured by other methods (31, 32) .
Creatinine in serum and urine was measured by an automated method based on the Jaffe reaction (33) in the central laboratory of University of Minnesota Hospital. The coefficient of variation for serum creatinine was less than 1 percent, and for urinary creatinine it was 2.5 percent. Creatinine clearance was computed as urinary creatinine (mg/minute) divided by serum creatinine (mg/ml). Raw clearance was then standardized to 1.73 m 2 of body surface. Plasma glucose was measured within 2 hours of blood draw in duplicate or triplicate with a Yellow Springs glucose analyzer (Yellow Springs Instrument Company, Yellow Springs, Ohio), employing a glucose oxidase method.
Blood pressure measurements
After a 5-minute rest period in the sitting position, blood pressure was measured twice with a randomzero instrument, using a standardized procedure. Hypertension was defined as follows: the mean of two pairs of random-zero measurements, from two different test days, being > 140 mmHg for systolic pressure or ^ 90 mmHg for diastolic pressure, or both; and/or the use of blood pressure-lowering medication prescribed by a physician.
Most participants had supervised 260-minute urine collections for AER and creatinine clearance completed twice at baseline and twice at 5 years' follow-up (on both oral glucose tolerance and Ensure-Plus test days). The paired AER measurements had withinsubject correlation coefficients of 0.89 at baseline and 0.78 at 5 years (p < 0.0001), while the reliability of creatinine clearance was somewhat lower: 0.73 at both time points (p < 0.0001). For further analyses, we used the mean of the paired within-subject measurements of both AER and creatinine clearance.
Statistical methods
Statistical analyses were performed with a VAX computer (Digital Equipment Corporation, Boston, Massachusetts) using SAS software (version 6.09; SAS Institute, Inc., Cary, North Carolina). Subjects in the stratified random sample who were found to have diabetes upon baseline testing (i.e., newly diagnosed cases) were pooled with the previously known diabetes cases. Since the distribution of AER values was highly skewed, data were transformed to the natural logarithms before statistical tests were applied. For creatinine clearance, the untransformed results are presented. Multiple regression was used to study AER and creatinine clearance as dependent variables, with glucose tolerance category, blood pressure, and other measurements as independent variables.
RESULTS
Distribution of AER and creatinine clearance values
The geometric mean AER measured in 455 persons at baseline was 4.2 /xg/minute; the natural logarithmic mean was 1.44 (standard deviation, 1.03). Low-level microalbuminuria (AER £15 but <45 /xg/minute) was seen in 4.2 percent (n = 19), somewhat higher values (AER ^45 but <175 /ig/minute) in 1.8 percent (n = 8), and overt proteinuria (AER ^175 /xg/minute) in 1.8 percent (n = 8). The maximum value was 2,070 pig/minute. These values, which included the oversampled diabetics, were somewhat higher than those in the general Wadena population: hi the stratified Goetz et al.
random sample (n = 374), the mean AER (unadjusted) was 3.6 /ig/minute, with a 10th percentile of 1.7, a 90th percentile of 8.1, and a maximum of 384.
Mean creatinine clearance at baseline was 95.3 ml/ minute (standard deviation, 27.8). Creatinine clearance less than 80 ml/minute was encountered in 28.1 percent (n = 128) of the participants. The minimum value was 13 ml/minute. These values were somewhat lower than those in the stratified random sample, wherein the mean was 100.0 ml/minute, with a 10th percentile of 68, a 90th percentile of 131, and a minimum of 27.
Relation between AER and creatinine clearance within subjects
At the baseline examination, there was no correlation between AER and creatinine clearance for the large number of subjects (n = 420) with AERs less than 15 /xg/minute (r = -0.01). In contrast, for the 35 subjects with AERs ^15 jig/minute at baseline, there was a negative correlation between baseline AER and creatinine clearance (r = -0.36, p = 0.03). These relations are shown in figure 1. 
Correlates of AER and creatinine clearance at baseline
The study included more old people than young people and slightly more women than men (table 1) . Among persons under age 40, geometric mean AER was lower in men than in women, although a larger proportion of young men than young women had albuminuria (AER > 15 /xg/minute). AER was substantially higher in men over age 59 than in women of corresponding age (p -0.04 for the interaction between AER, sex, and age in a linear model with age entered as a continuous variable). As expected, creatinine clearance was somewhat higher in men than in women, independent of age (p < 0.0001). Low creatinine clearance was particularly prevalent in men and women aged 60 years or more. It decreased approximately 1 ml/minute per year of age in each sex (p < 0.0001).
AER (both before and after adjustment for age, sex, and other factors listed in the first footnote of table 2) was higher in subjects with NTDDM (5.4 /xg/minute in those not taking insulin, 9.4 jig/minute in those taking insulin) and in subjects with IDDM (14.1 /xg/minute) than in those with normal glucose tolerance (3.8 /xg/ minute). This was not the case, however, for subjects with impaired glucose tolerance (AER = 3.7 /xg/ minute) (all adjusted values; table 2). AER increased consistently across blood pressure categories, including high-normal blood pressure, and was particularly high in persons with systolic blood pressure >-160 mmHg. Further analyses in 5-mmHg intervals (not shown) suggested that mean AER does not change with blood pressure below 120 mmHg but begins to rise gradually as systolic blood pressure increases above this level. Findings were similar for diastolic blood pressure, but were weaker for categorical hypertension or hypertension treatment (data not shown). AER displayed a U-shaped relation with body mass index (weight (kg)/height (m)
2 ), with minimum values in the body mass index category 26.5-28.4. By smoking status, AER was highest in the current smokers, although this difference did not achieve statistical significance. Unadjusted values were similar (data not shown).
There was a strong negative gradient of unadjusted creatinine clearance across categories of glucose tolerance (data not shown), but there was little difference in creatinine clearance among the glucose tolerance categories after adjustment for age (data not shown) or for all factors (table 3) . However, creatinine clearance was reduced in persons with systolic blood pressure 1 60 mmHg compared with those with lower blood pressure, even after adjustment. An excess prevalence of low creatinine clearance was seen in persons with systolic blood pressures between 140 and 159 mmHg. There was lower adjusted creatinine clearance at both high and low body mass indices, although the inverted U shape was not entirely consistent. Adjusted creatinine clearance was highest in current smokers and lowest in never smokers. As was the case for AER, findings were similar for diastolic blood pressure but were weaker for categorical hypertension (data not shown).
Because findings (data not shown) in four groups defined by sex and age (cut at 50 years) were similar to those presented here, it is improbable that large differences in the above relations between age and sex groups were overlooked.
Changes over 5 years in AER and creatinine clearance
The interpretation of changes in major variables within subjects was complicated by differential nonresponse (dropout). First, there was some tendency for those with a higher AER or lower creatinine clearance not to return for the 5-year follow-up examination. Nonresponse was 24 percent in persons with AERs less than 15 jig/minute, 30 percent for those with AERs & 15 but < 175 ^ig/minute, and 50 percent in the eight participants with AERs > 175 ^ig/minute. Nonresponse was 20 percent in persons with creatinine clearance S: 80 ml/minute, compared with 38 percent in those with creatinine clearance less than 80 ml/ minute. Reflecting these differences, the baseline mean AER in the nonresponders, while still normal, was somewhat higher than in those who returned for the 5-year follow-up examination (5.3 vs. 3.9 yugl minute; p -0.02). Similarly, baseline mean creatinine clearance in the nonresponders was somewhat lower than that in those who returned for the 5-year follow-up examination (85.6 vs. 98.5 ml/minute; p -0.0002).
There was also greater nonresponse in persons who took insulin and persons with hypertension. As table 4 shows, nonresponse was 2.6 times higher in those taking insulin and/or those with systolic blood pressure ^ 160 mmHg. This differential nonresponse largely explained the differential nonresponse in the dependent variables, AER and creatinine clearance. For the 407 participants at baseline who neither took insulin nor had a systolic blood pressure 2: 160 mmHg, nonresponse was 21 percent, independent of the level of AER or creatinine clearance. Nonresponse was much greater (at 54 percent) in the remaining 48 participants.
Among the 343 persons who returned at 5 years, the geometric mean AER was unchanged: The baseline value was 3.9 fig/minute and the follow-up value was 3.8 /Ag/minute {p = 0.4). Mean creatinine clearance decreased by 5.5 ml/minute, from the baseline value of 98.5 to a follow-up value of 93.0 (p = 0.0001), with 23 percent of participants having a value less than 80 ml/minute at baseline and 32 percent at 5 years. These changes in AER and creatinine clearance may be underestimates, however, because of the differential nonresponse noted above.
We therefore separately examined changes in the 321 persons who were not taking insulin and had a systolic blood pressure less than 160 mmHg (high response group) and in the 22 persons who were taking insulin or had a systolic blood pressure > 160 mmHg (low response group). AER decreased by 6 percent over 5 years in the 321 persons in the high response group, but it increased by 12 percent among the 22 persons in the low response group. Neither of these changes was statistically significant, however, nor did either one persist after adjustment for potentially confounding factors. Creatinine clearance decreased by 5.1 ml/minute over 5 years in the 321 persons in the high response group and by 10.6 ml/minute among the 22 persons in the low response group. Both of these changes were statistically significant and persisted after adjustment. Furthermore, creatinine clearance in women aged 20-39 years increased nonsignificantly, in contrast to a decrease in every other age/sex group. We studied additional correlates of changes in AER and creatinine clearance among the 321 people in the high response group. There were no statistically significant differences in AER changes over 5 years among categories of baseline AER, baseline creatinine clearance, glucose tolerance, systolic blood pressure, or smoking history, either before or after adjustment for baseline values. There were no noteworthy changes in creatinine clearance across categories of baseline AER, baseline creatinine clearance, or systolic blood pressure. Among glucose tolerance categories, the rate of decline of creatinine clearance in the subgroups "impaired glucose tolerance" and "NIDDM-no insulin" (adjusted values: -6.4 and -7.3 ml/minute, respectively) was greater than that in the normal glucose tolerance group (-4.3 ml/minute), but the differences among the groups were not statistically significant. Relations of the two dependent variables with body mass index were inconsistent, but both deteriorated somewhat in normal-weight subjects. AER did not change over time with respect to smoking status (table 5) . The relation between baseline smoking behavior and change in creatinine clearance over time was different from the cross-sectional association of baseline smoking behavior and baseline creatinine clearance. Both unadjusted and adjusted mean values for creatinine clearance fell over 5 years, significantly more for current smokers (9.8 ml/minute, adjusted) and ex-smokers (8.0 ml/minute) than for never smokers (2.3 ml/minute). This decelerated decline in creatinine clearance over 5 years' aging in never smokers was then investigated in the crosssectional baseline data, but the difference in baseline creatinine clearance per year of age did not depend on baseline smoking status.
DISCUSSION
The data presented here come from a communitybased US population sample of free-living adults of Northern European origin. They indicate the importance of NIDDM and blood pressure as risk factors associated with increased AER. This is in basic agreement with studies from Northern Europe (18, (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) , populations of similar heritage living elsewhere (44, 45) , and one similar US population (22, 46) . Cultural 14 
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* AER, albumin excretion rate; C,^, creatinine clearance. and environmental differences that may exist between North Americans in Wadena, Minnesota, and their European contemporaries are not sufficient to obscure these associations.
We found in Wadena adults that geometric mean AER was slightly higher in young women than in young men. AER increased with age in men but not in women, so that it was somewhat higher in older men than in either women or younger men. We feel that our data do not support the notion that young women have a greater propensity for urinary albumin loss than young men (20, 47, 48) , for two reasons. First, despite our efforts to avoid urine collection during menses, it is possible that trace amounts of blood in specimens taken from young women explain the higher mean AER found in young women than in young men. Second, Wadena young men had an increased AER more frequently than did young women. The higher levels of AER seen in older men than in older women agree with the findings of Metcalf et al. (45) in 40-to 78-year-old New Zealand workers of various ethnicities. There has been little study of age associations with AER. Vestbo et al. (48) give age associations that vary according to the measure of albumin excretion used. More data are needed in order to evaluate age and sex differences.
The lack of association between moderate hyperglycemia (impaired glucose tolerance) and increased AER in Wadena adults is of particular interest, since it has been proposed that increased AER may be a precursor of the diabetic state (49) . We could find no other US studies reporting AER in European Americans with impaired glucose tolerance. The Wadena results contrast with a number of reports of such an association in non-European populations (20, 21, 45, 49, 50) . In addition, two recent studies of Caucasian populations are pertinent to our findings. The first is Metcalf et al.'s cross-sectional study (45) of a large number of New Zealanders aged 40 and over. Geometric mean urinary albumin concentration in persons with impaired glucose tolerance exceeded that in men and women with normal glucose tolerance by 1.3 mg/liter among those of European descent but by 7.0 mg/liter in Maoris and Pacific Islanders, with a corresponding pattern of prevalence of albuminuria. The other pertinent study is that by Mykkanen et al. (51) , who randomly sampled 1,300 65-to 74-year-old residents of Kuopio, Finland. They too found mild but statistically significant increases in various measures of urinary albumin in subjects with impaired glucose tolerance as compared with those with normal glucose tolerance.
There seems to be no simple confounding factor that could explain our failure to observe an association between impaired glucose tolerance and increased AER in the Wadena subjects, at either baseline or 5 years. Our subjects in Wadena included persons of a wide age range (20->90 years); we employed duplicate urine collections at each time point to offset the well-known day-to-day variation in AER within subjects (32) ; and the 260-minute urine collections were carefully supervised to reduce variability to a minimum. Thus, our methodology should have been at least as sensitive as that of the studies cited above. We await other studies of impaired glucose tolerance in American populations with interest.
Among persons with NJDDM, a greater prevalence of increased albuminuria in non-Europeans versus Eu- ropeans is the usual (20, 21, 45, 52, 53) but not universal (54) finding. Not only is hyperglycemia less common among Europeans (20, 21, 45, 55) but the hyperglycemics among them appear to be less susceptible to kidney damage (56) (57) (58) . The possibility that susceptibility to kidney damage from hyperglycemia may be partly under genetic control has been brought out by family studies of IDDM subjects (59) .
Creatinine clearance, in contrast to AER, was markedly affected by both age and sex, with low clearance (<80 ml/minute) being observed in approximately half of the women and men over age 59. The sex difference in creatinine clearance has only recently been documented by direct observations, which consistently show that men have higher clearances than women of the same age and race (60) (61) (62) (63) (64) . An inverse association between age and creatinine clearance has been reported in women in cross-sectional studies (60, 63) , parallel to that observed in men (65, 66) . Longitudinal data in women are few (61) and appear to be restricted to women over age 40. The Wadena 5-year data suggest that the age-related decline in glomerular filtration rate may begin later in women than in men. A difference in dietary protein intake could be one reason for such a difference (67). Although we have not examined dietary information in the Wadena study, others have observed that men eat more protein per kilogram of body weight than do women (68) .
Age-adjusted creatinine clearance was not related to glucose tolerance category in cross-sectional analysis. There was, however, a moderately greater (though not statistically significant) 5-year rate of decline in creatinine clearance in both the impaired glucose tolerance and NIDDM-no insulin groups than in the normal glucose tolerance group. This slow decline of glomerular function in Wadena survivors suggests that impaired kidney function is a marker for other diseases of the cardiovascular system. Thus, many persons who are under treatment for end-stage renal failure or are found at autopsy to have nodular glomerulosclerosis have NIDDM (69, 70) , but the 10-year follow-up study of 503 NIDDM subjects reported by Schmitz and Vaeth (34) found uremia to be markedly overshadowed by cardiovascular disease as a cause of death. Although no significant progression to overt renal disease was observed within 5 years in our subjects with increased AER and NTDDM, longer follow-up would be needed to assess this risk fully.
A positive relation between blood pressure and increased AER was noted in the 1962 Bedford Study (1, 71) and in many studies of diabetic and nondiabetic subjects that have been conducted since then (5) (6) (7) (8) (9) (10) (11) (12) (13) . In agreement with these findings, the Wadena population showed hypertension to be a strong and significant baseline correlate of both AER and creatinine clearance. There was a consistent tendency in the Wadena data toward increased AER for systolic blood pressure levels as low as 120 mmHg; to our knowledge, other investigators have not examined whether there is a blood pressure threshold for albuminuria. These findings were independent of glucose tolerance status. Only the group with baseline systolic blood pressure ^160 mmHg (in whom response rate was poor) showed an accelerated 5-year decline in creatinine clearance: 10.6 ml/minute, versus 5.1 ml/minute in persons with systolic blood pressure less than 160 mmHg.
The overall lack of 5-year changes within subjects was unexpected and should be accepted with some caution because of the differential nonresponse rate. It remains possible that changes in AER and creatinine clearance were hidden by relatively short follow-up or by poor response among persons who would theoretically be the most likely to experience accelerated change. It appears that the differential dropout rate may have been motivated by discomfort and dislike of testing on the part of the sicker participants, which is associated with worse kidney function.
Although there has been much evidence that cigarette smoking may be harmful to the kidneys in diabetic subjects (72) (73) (74) (75) (76) (77) , it seems not to have been recognized that smoking may be responsible for accelerated declines in glomerular filtration rate in the general public. This could be due to the pervasiveness of smoking among US men in the 1950s, 1960s, and 1970s, when.some important early studies of aging (65, 66) were being conducted without reporting of smoking status. The baseline observation in Wadena that creatinine clearance was higher in current smokers than in never smokers might be explained by evidence that renal hyperfiltration (an increased glomerular filtration rate) may be caused by cigarette smoking (76) .
With respect to cause-and-effect relations, our data suggest that hypertension and the diabetic state, since they are independently associated with abnormal AER and creatinine clearance, cause kidney damage through different mechanisms. Diabetes may act through biochemical change in the glomerular filtration barrier, altering its charge (78, 79) , or in the filtration properties of circulating albumin through glycation (80) . Hypertension, a heterogeneous condition, may in some cases operate through altered intraglomerular pressure (81) . Both types of injury may be reversible with treatment (82, 83) .
In summary, diabetes and hypertension appear to be major risk factors for kidney damage in both men and women, while mild increases in blood pressure, smoking, and perhaps obesity may be contributing factors. Since impaired glucose tolerance was not associated with increased albuminuria in this study, Wadena residents, who are descendants of Northern Europeans, may be somewhat resistant to the effects of hyperglycemia on the kidney in comparison with other ethnic groups. Be that as it may, microalbuminuria appears to be a marker of accelerated cardiovascular disease, as well as of end-stage kidney disease (34) . Therefore, prevention and aggressive treatment of diabetes and even modest blood pressure elevation, when these conditions are accompanied by microalbuminuria, could reduce the frequency of both end-stage kidney disease and other cardiovascular diseases in all North American adults.
